Vaccinex, Inc.

Organization

Rochester, NY, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-CXCL13 antibodies and methods of using the same
- Patent number 11,981,730
- Issue date May 14, 2024
- Vaccinex, Inc.
- Ekaterina Klimatcheva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Integral membrane protein display on poxvirus extracellular envelop...
- Patent number 11,976,383
- Issue date May 7, 2024
- Vaccinex, Inc.
- Ernest S. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-CCR8 antibodies and uses thereof
- Patent number 11,859,000
- Issue date Jan 2, 2024
- Vaccinex Inc.
- Pamela M. Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 th...
- Patent number 11,660,330
- Issue date May 30, 2023
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Brian Czerniecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules for the treatment of Rett sy...
- Patent number 11,597,765
- Issue date Mar 7, 2023
- Vaccinex, Inc.
- Yilin Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with a semaphorin-4D antibody in combination wi...
- Patent number 11,572,408
- Issue date Feb 7, 2023
- Vaccinex, Inc.
- Elizabeth Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules for modulation of blood brai...
- Patent number 11,534,488
- Issue date Dec 27, 2022
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human anti-semaphorin 4D antibody
- Patent number 11,427,634
- Issue date Aug 30, 2022
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD100 antibodies and methods for using the same
- Patent number 11,274,149
- Issue date Mar 15, 2022
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of semaphorin-4D inhibitory molecules with an immune modulating...
- Patent number 11,078,295
- Issue date Aug 3, 2021
- Vaccinex, Inc.
- Elizabeth Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Integral membrane protein display on poxvirus extracellular envelop...
- Patent number 10,870,707
- Issue date Dec 22, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polynucleotides encoding anti-CXCL13 antibodies
- Patent number 10,829,550
- Issue date Nov 10, 2020
- Vaccinex, Inc.
- Ekaterina Klimatcheva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules for treating neurodegenerati...
- Patent number 10,800,853
- Issue date Oct 13, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for selecting polynucleotides encoding antigen-specific immu...
- Patent number 10,662,422
- Issue date May 26, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Methods for producing polynucleotide libraries in vaccinia virus/eu...
- Patent number 10,640,765
- Issue date May 5, 2020
- Vaccinex, Inc.
- Ernest Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Integral membrane protein display on poxvirus extracellular envelop...
- Patent number 10,577,427
- Issue date Mar 3, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Integral membrane protein display on poxvirus extracellular envelop...
- Patent number 10,550,199
- Issue date Feb 4, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of anti-semaphorin-4D antibodies in combination with an immune...
- Patent number 10,526,414
- Issue date Jan 7, 2020
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules to promote neurogenesis foll...
- Patent number 10,494,440
- Issue date Dec 3, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of semaphorin-4D binding molecules for treating neurodegenerati...
- Patent number 10,385,136
- Issue date Aug 20, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating multiple sclerosis using anti-CD20 antibodies
- Patent number 10,301,393
- Issue date May 28, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified glycolipids and methods of making and using the same
- Patent number 10,111,950
- Issue date Oct 30, 2018
- Vaccinex, Inc.
- Steven A. Porcelli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CXCL13 antibodies and methods of using the same
- Patent number 9,963,504
- Issue date May 8, 2018
- Vaccinex, Inc.
- Ekaterina Klimatcheva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the treatment of B cell-mediated inflammatory diseases
- Patent number 9,890,213
- Issue date Feb 13, 2018
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of antibodies or antigen-binding fragments thereof that specifi...
- Patent number 9,828,435
- Issue date Nov 28, 2017
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted CD1d molecules
- Patent number 9,809,654
- Issue date Nov 7, 2017
- Vaccinex, Inc.
- Bruno Robert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for increasing immunoglobulin A levels
- Patent number 9,790,271
- Issue date Oct 17, 2017
- Vaccinex, Inc.
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins to facilitate selection of cells infected with spec...
- Patent number 9,708,601
- Issue date Jul 18, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Method for selecting polynucleotides encoding antigen-specific immu...
- Patent number 9,701,958
- Issue date Jul 11, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Anti-CD100 neutralizing antibodies and methods of using the same
- Patent number 9,676,840
- Issue date Jun 13, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHODS TO SELECT ANTIBODIES SPECIFIC TO COMPLEX MEMBRANE ANTIGENS
- Publication number 20240093177
- Publication date Mar 21, 2024
- Vaccinex, Inc.
- Malgorzata Gil-Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 TH...
- Publication number 20240050544
- Publication date Feb 15, 2024
- H. Lee Moffitt Cancer Center and Research Institute, Inc. (A Florida Non-Prof...
- Brian Czerniecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE AND HTT-LOWERING AG...
- Publication number 20230331863
- Publication date Oct 19, 2023
- Vaccinex, Inc.
- Elizabeth Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PREDICTIVE OUTCOME PROFILING FOR USE OF AN ANTI-SEMAPHORIN-4D BINDI...
- Publication number 20230101618
- Publication date Mar 30, 2023
- Vaccinex, Inc.
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
- Publication number 20220356249
- Publication date Nov 10, 2022
- Vaccinex, Inc.
- Ernest S. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME
- Publication number 20220185884
- Publication date Jun 16, 2022
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR THE TREATMENT OF RETT SY...
- Publication number 20210403559
- Publication date Dec 30, 2021
- Vaccinex, Inc.
- Yilin Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CXCL13 BINDING MOLECULES TO PROMOTE PERIPHERAL NERVE REGENER...
- Publication number 20210388075
- Publication date Dec 16, 2021
- Vaccinex, Inc.
- Simone DiGiovanni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...
- Publication number 20210348158
- Publication date Nov 11, 2021
- Vaccinex, Inc.
- Ernest S. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES WITH AN IMMUNE MODULATING...
- Publication number 20210324103
- Publication date Oct 21, 2021
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR8 ANTIBODIES AND USES THEREOF
- Publication number 20210238292
- Publication date Aug 5, 2021
- Vaccinex, Inc.
- Pamela M. HOLLAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WI...
- Publication number 20210179708
- Publication date Jun 17, 2021
- Vaccinex, Inc.
- Elizabeth EVANS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME
- Publication number 20210087263
- Publication date Mar 25, 2021
- Vaccinex, Inc.
- Ekaterina Klimatcheva
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINED INHIBITION OF SEMAPHORIN-4D AND TGF-BETA AND COMPOSITIONS...
- Publication number 20210032322
- Publication date Feb 4, 2021
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
- Publication number 20210032329
- Publication date Feb 4, 2021
- Vaccinex, Inc.
- Ernest S. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 TH...
- Publication number 20200397881
- Publication date Dec 24, 2020
- H. Lee Moffitt Cancer Center and Research Institute, Inc. (A Florida Non-Prof...
- Brian Czerniecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY
- Publication number 20200317788
- Publication date Oct 8, 2020
- Vaccinex, Inc.
- Terrence Lee Fisher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...
- Publication number 20200216562
- Publication date Jul 9, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NE...
- Publication number 20190383836
- Publication date Dec 19, 2019
- Vaccinex, Inc.
- Maurice ZAUDERER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAI...
- Publication number 20190358321
- Publication date Nov 28, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...
- Publication number 20190322757
- Publication date Oct 24, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...
- Publication number 20190276556
- Publication date Sep 12, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF ANTI-SEMAPHORIN-4D ANTIBODIES MOLECULES WITH AN IMMUNE MODUL...
- Publication number 20190248914
- Publication date Aug 15, 2019
- Vaccinex, Inc.
- Elizabeth Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EU...
- Publication number 20190241889
- Publication date Aug 8, 2019
- Vaccinex, Inc.
- Ernest SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMPROVED METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA...
- Publication number 20190169606
- Publication date Jun 6, 2019
- Vaccinex, Inc.
- Ernest SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...
- Publication number 20190112388
- Publication date Apr 18, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME
- Publication number 20180244764
- Publication date Aug 30, 2018
- Vaccinex, Inc.
- Ekaterina Klimatcheva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH AN IM...
- Publication number 20170335008
- Publication date Nov 23, 2017
- Vaccinex, Inc.
- Elizabeth E. Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES
- Publication number 20170312356
- Publication date Nov 2, 2017
- Vaccinex, Inc.
- Alena DONDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME
- Publication number 20170306017
- Publication date Oct 26, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
88796128 - SCIENCE IN THE SERVICE OF MEDICINE
- Serial number 88796128
- Registration number 6136113
- Filing date Feb 13, 2020
- Vaccinex, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88125908 - SCIENCE IN THE SERVICE OF MEDICINE
- Serial number 88125908
- Filing date Sep 20, 2018
- Vaccinex Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78616355 - ACTIVMAB
- Serial number 78616355
- Registration number 3161846
- Filing date Apr 25, 2005
- Vaccinex, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
78298560 - VACCINEX
- Serial number 78298560
- Registration number 2906537
- Filing date Sep 10, 2003
- Vaccinex, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
76317611 - VACCINEX
- Serial number 76317611
- Filing date Sep 26, 2001
- Vaccinex, Inc.
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 19

Research Projects

Information Research Project
New Target Antigens for Prostate Cancer Immunotherapy
- Application id 6889875
- Award notice date Apr 20, 2005
Information Research Project
Human Monoclonal Antibodies for Bioterrorism Defense
- Application id 6885399
- Award notice date Apr 11, 2005
Information Research Project
Functional Identification of Cancer Regulators
- Application id 6855158
- Award notice date Feb 24, 2005
Information Research Project
Monoclonal Antibody Therapy to Combat Osteoporosis
- Application id 6788328
- Award notice date May 14, 2004
Information Research Project
New Target Antigens for Prostate Cancer Immunotherapy
- Application id 6787434
- Award notice date Apr 27, 2004
Information Research Project
Human Monoclonal Antibodies for Bioterrorism Defense
- Application id 6788449
- Award notice date Apr 14, 2004
Information Research Project
A METHOD TO IDENTIFY UPSTREAM REGULATORS OF ONCOGENES
- Application id 6724874
- Award notice date Mar 2, 2004
Information Research Project
Functional Identification of Cancer Regulators
- Application id 6735563
- Award notice date Feb 13, 2004
Information Research Project
Genetic Selection System to Clone Osteogenic Regulators
- Application id 6626021
- Award notice date Jul 15, 2003
Information Research Project
C35: A Target for Bladder and Breast Cancer Therapy
- Application id 6404535
- Award notice date Aug 23, 2002
Information Research Project
C35: A Target for Bladder and Breast Cancer Therapy
- Application id 6522480
- Award notice date Jul 24, 2002
Information Research Project
Genetic Selection System to Clone Osteogenic Regulators
- Application id 6484402
- Award notice date May 13, 2002
Information Research Project
Genetic Selection to Clone Chondrogenic Regulators
- Application id 6404323
- Award notice date Aug 17, 2001
Information Research Project
NEW TARGET ANTIGENS FOR PROSTATE CANCER VACCINES
- Application id 6335433
- Award notice date Feb 5, 2001
Information Research Project
NEW TARGET ANTIGENS FOR PROSTATE CANCER VACCINES
- Application id 2903476
- Award notice date Feb 16, 2000
Information Research Project
GENE EXPRESSION AND IMMUNOGENS OF UROEPITHELIAL TUMORS
- Application id 6075914
- Award notice date Jan 27, 2000
Information Research Project
ANTIGENS OF BRONCHIAL EPITHELIAL TUMORS
- Application id 6028375
- Award notice date Feb 16, 1999
Information Research Project
ANTIGENS OF BRONCHIAL EPITHELIAL TUMORS
- Application id 2717559
- Award notice date Aug 21, 1998
Information Research Project
A METHOD TO IDENTIFY UPSTREAM REGULATORS OF ONCOGENES
- Application id 6578510

Vaccinex, Inc.

Organization

Patents Grantslast 30 patents

Anti-CXCL13 antibodies and methods of using the same

Integral membrane protein display on poxvirus extracellular envelop...

Anti-CCR8 antibodies and uses thereof

Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 th...

Use of semaphorin-4D binding molecules for the treatment of Rett sy...

Treatment of cancer with a semaphorin-4D antibody in combination wi...

Use of semaphorin-4D binding molecules for modulation of blood brai...

Human anti-semaphorin 4D antibody

Anti-CD100 antibodies and methods for using the same

Use of semaphorin-4D inhibitory molecules with an immune modulating...

Integral membrane protein display on poxvirus extracellular envelop...

Polynucleotides encoding anti-CXCL13 antibodies

Use of semaphorin-4D binding molecules for treating neurodegenerati...

Method for selecting polynucleotides encoding antigen-specific immu...

Methods for producing polynucleotide libraries in vaccinia virus/eu...

Integral membrane protein display on poxvirus extracellular envelop...

Integral membrane protein display on poxvirus extracellular envelop...

Use of anti-semaphorin-4D antibodies in combination with an immune...

Use of semaphorin-4D binding molecules to promote neurogenesis foll...

Use of semaphorin-4D binding molecules for treating neurodegenerati...

Methods of treating multiple sclerosis using anti-CD20 antibodies

Modified glycolipids and methods of making and using the same

Anti-CXCL13 antibodies and methods of using the same

Methods for the treatment of B cell-mediated inflammatory diseases

Use of antibodies or antigen-binding fragments thereof that specifi...

Targeted CD1d molecules

Methods for increasing immunoglobulin A levels

Fusion proteins to facilitate selection of cells infected with spec...

Method for selecting polynucleotides encoding antigen-specific immu...

Anti-CD100 neutralizing antibodies and methods of using the same

Patents Applicationslast 30 patents

METHODS TO SELECT ANTIBODIES SPECIFIC TO COMPLEX MEMBRANE ANTIGENS

COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 TH...

COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE AND HTT-LOWERING AG...

PREDICTIVE OUTCOME PROFILING FOR USE OF AN ANTI-SEMAPHORIN-4D BINDI...

HUMAN ANTI-SEMAPHORIN 4D ANTIBODY

ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR THE TREATMENT OF RETT SY...

USE OF CXCL13 BINDING MOLECULES TO PROMOTE PERIPHERAL NERVE REGENER...

INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...

USE OF SEMAPHORIN-4D INHIBITORY MOLECULES WITH AN IMMUNE MODULATING...

ANTI-CCR8 ANTIBODIES AND USES THEREOF

TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WI...

ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME

COMBINED INHIBITION OF SEMAPHORIN-4D AND TGF-BETA AND COMPOSITIONS...

HUMAN ANTI-SEMAPHORIN 4D ANTIBODY

COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 TH...

SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY

INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...

EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NE...

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAI...

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...

INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...

USE OF ANTI-SEMAPHORIN-4D ANTIBODIES MOLECULES WITH AN IMMUNE MODUL...

METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA VIRUS/EU...

IMPROVED METHODS FOR PRODUCING POLYNUCLEOTIDE LIBRARIES IN VACCINIA...

INTEGRAL MEMBRANE PROTEIN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...

ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME

USE OF SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH AN IM...

MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES

ANTI-CD100 ANTIBODIES AND METHODS FOR USING THE SAME

Trademarklast 30 trademarks

88796128 - SCIENCE IN THE SERVICE OF MEDICINE

88125908 - SCIENCE IN THE SERVICE OF MEDICINE

78616355 - ACTIVMAB

78298560 - VACCINEX

76317611 - VACCINEX

NIH Research Projectlast 12 months

Research Projects

New Target Antigens for Prostate Cancer Immunotherapy

Human Monoclonal Antibodies for Bioterrorism Defense

Functional Identification of Cancer Regulators

Monoclonal Antibody Therapy to Combat Osteoporosis

New Target Antigens for Prostate Cancer Immunotherapy

Human Monoclonal Antibodies for Bioterrorism Defense

A METHOD TO IDENTIFY UPSTREAM REGULATORS OF ONCOGENES

Functional Identification of Cancer Regulators